Literature DB >> 20625881

GADD34 suppresses wound healing by upregulating expression of myosin IIA.

Chie Tanaka1, Sachiko Ito, Naomi Nishio, Yasuhiro Kodera, Hidetoshi Sakurai, Haruhiko Suzuki, Akimasa Nakao, Ken-Ichi Isobe.   

Abstract

Wound healing consists of sequential steps of tissue repair, and cell migration is particularly important. In order to analyze the potential function of growth arrest and DNA damage inducible protein 34 (GADD34) in tissue repair, we performed in vitro and in vivo wound healing experiments. In an in vitro scratch assay, GADD34 knockout (KO) mouse embryonic fibroblasts (MEFs) had higher migration rates than did wild type (WT) MEFs. Furthermore, the rate of wound closure was faster in GADD34 KO MEFs than in WT MEFs. Using in vivo punch biopsy assays, GADD34 KO mice had accelerated wound healing compared to WT mice. WT mice expressed higher amounts of myosin IIA in migrating macrophages and myofibroblasts than did GADD34 KO mice. These results indicate that GADD34 negatively regulates cell migration in wound healing via expression of myosin IIA.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20625881     DOI: 10.1007/s11248-009-9347-z

Source DB:  PubMed          Journal:  Transgenic Res        ISSN: 0962-8819            Impact factor:   2.788


  22 in total

1.  Stress-induced gene expression requires programmed recovery from translational repression.

Authors:  Isabel Novoa; Yuhong Zhang; Huiqing Zeng; Rivka Jungreis; Heather P Harding; David Ron
Journal:  EMBO J       Date:  2003-03-03       Impact factor: 11.598

Review 2.  Cellular motility driven by assembly and disassembly of actin filaments.

Authors:  Thomas D Pollard; Gary G Borisy
Journal:  Cell       Date:  2003-02-21       Impact factor: 41.582

3.  Nonmuscle myosin IIb is involved in the guidance of fibroblast migration.

Authors:  Chun-Min Lo; Denis B Buxton; Gregory C H Chua; Micah Dembo; Robert S Adelstein; Yu-Li Wang
Journal:  Mol Biol Cell       Date:  2003-12-29       Impact factor: 4.138

4.  Heme-regulated eIF2alpha kinase (HRI) is required for translational regulation and survival of erythroid precursors in iron deficiency.

Authors:  A P Han; C Yu; L Lu; Y Fujiwara; C Browne; G Chin; M Fleming; P Leboulch; S H Orkin; J J Chen
Journal:  EMBO J       Date:  2001-12-03       Impact factor: 11.598

5.  The role of myosin II motor activity in distributing myosin asymmetrically and coupling protrusive activity to cell translocation.

Authors:  John Kolega
Journal:  Mol Biol Cell       Date:  2006-07-19       Impact factor: 4.138

6.  Response of neurons to an irreversible inhibition of endoplasmic reticulum Ca(2+)-ATPase: relationship between global protein synthesis and expression and translation of individual genes.

Authors:  T Mengesdorf; S Althausen; I Oberndorfer; W Paschen
Journal:  Biochem J       Date:  2001-06-15       Impact factor: 3.857

7.  Myosin IIA regulates cell motility and actomyosin-microtubule crosstalk.

Authors:  Sharona Even-Ram; Andrew D Doyle; Mary Anne Conti; Kazue Matsumoto; Robert S Adelstein; Kenneth M Yamada
Journal:  Nat Cell Biol       Date:  2007-02-18       Impact factor: 28.824

8.  Oxidant-induced vascular endothelial growth factor expression in human keratinocytes and cutaneous wound healing.

Authors:  Chandan K Sen; Savita Khanna; Bernard M Babior; Thomas K Hunt; E Christopher Ellison; Sashwati Roy
Journal:  J Biol Chem       Date:  2002-06-14       Impact factor: 5.157

9.  Human nonmuscle myosin heavy chain mRNA: generation of diversity through alternative polyadenylylation.

Authors:  C G Saez; J C Myers; T B Shows; L A Leinwand
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

10.  Nonmuscle myosin heavy chain IIA mediates integrin LFA-1 de-adhesion during T lymphocyte migration.

Authors:  Nicole A Morin; Patrick W Oakes; Young-Min Hyun; Dooyoung Lee; Y Eugene Chin; Eugene Y Chin; Michael R King; Timothy A Springer; Motomu Shimaoka; Jay X Tang; Jonathan S Reichner; Minsoo Kim
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  1 in total

1.  Tyrosine kinase inhibitor discontinuation in patients with chronic myeloid leukemia: a single-institution experience.

Authors:  Kamal Chamoun; Hagop Kantarjian; Rami Atallah; Graciela Nogueras Gonzalez; Ghayas C Issa; Mary Beth Rios; Guillermo Garcia-Manero; Gautam Borthakur; Farhad Ravandi; Nitin Jain; Naval Daver; Marina Konopleva; Courtney D DiNardo; Tapan Kadia; Naveen Pemmaraju; Elias Jabbour; Jorge Cortes
Journal:  J Hematol Oncol       Date:  2019-01-03       Impact factor: 17.388

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.